Radiation therapy for early stage unfavorable Hodgkin lymphoma: is dose reduction feasible?
Laskar S, Kumar DP, Khanna N, Menon H, Sengar M, Arora B, Gujral S, Shet T, Sridhar E, Rangarajan V, Muckaden MA, Nair R, Banavali S.
Laskar S, et al. Among authors: shet t.
Leuk Lymphoma. 2014 Oct;55(10):2356-61. doi: 10.3109/10428194.2013.871631. Epub 2014 Mar 7.
Leuk Lymphoma. 2014.
PMID: 24354681